SION Reports $75.3M Net Loss, $60.3M R&D Spend, $310.3M Cash, Operations Funded into 2028
Sionna Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $40.90
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS